Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

KRX/207940 stock hub

KRX/207940 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

KRX/207940is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

68.1T

Korea Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

KRX/207940

In the news

Latest news · KRX/207940

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E35.4

P25 9.8P50 17.1P75 31.9

Trailing P/E35.5

P25 12P50 23.1P75 39.5

ROEn/a

P25 -17.1P50 0.7P75 8.5

ROIC23.8

P25 -9P50 1.3P75 6.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All KRX/207940 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

173

Groups with data

Currency

KRW

Showing 173 of 173 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Korea
Country code	KR
Employees	4,770
Employees Change	1,884%
Employees Change Percent	65.28
Enterprise value	KRW 67.4T
Exchange	Korea Stock Exchange
Financial currency	KRW
First seen	2026-05-10
Industry	Biotechnology
Isin	KR7207940008
Last refreshed	2026-05-10
Market cap	KRW 68.1T
Price	KRW 1.5M
Price currency	KRW
Rev Per Employee	926,660,250.24x
Sector	Healthcare
Sic	2836
Symbol	krx/207940
Website	https://samsungbiologics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.82%
EV Earnings	35.09x
EV/EBIT	30.36x
EV/Sales	14.01x
Forward P/E	35.38x
P/B ratio	8.6x
P/E ratio	35.45x
P/S ratio	14.15x
PE Ratio10 Y	96.89x
PE Ratio3 Y	54.97x
PE Ratio5 Y	80x
PEG ratio	0.64x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	46.14%
Gross margin	55.15%
Gross Profit	KRW 2.7T
Gross Profit Growth	2.75%
Gross Profit Growth Q	-6.61%
Gross Profit Growth3 Y	19.07%
Gross Profit Growth5 Y	43.7%
Net Income	KRW 1.9T
Net Income Growth	50.21%
Net Income Growth Q	24.88%
Net Income Growth Quarters	8%
Net Income Growth Years	6%
Net Income Growth3 Y	34.33%
Net Income Growth5 Y	48.59%
Pretax Margin	48.21%
Profit Margin	39.93%
Profit Per Employee	KRW 370M
Profitable Years	8
Roa5y	5.6
ROCE	24
Roe5y	11.27
ROIC	23.76
Roic5y	11.27

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	11.48%
Cagr3y	13.34%
Cagr5y	7.84%
EPS Growth Quarters	8
EPS Growth Years	6
Revenue Growth	-1.73x
Revenue Growth Q	-3.18x
Revenue Growth Years	1x
Revenue Growth3 Y	14.45x
Revenue Growth5 Y	31.63x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	KRW 0.33
Assets	KRW 12T
Cash	KRW 1.6T
Current Assets	KRW 4.7T
Current Liabilities	KRW 2.7T
Debt	KRW 919B
Debt Equity	KRW 0.12
Equity	KRW 7.9T
Liabilities	KRW 4.1T
Long Term Assets	KRW 7.3T
Long Term Liabilities	KRW 1.3T
Net Cash	KRW 701B
Net Cash By Market Cap	KRW 1.03
Net Debt Equity	KRW -0.09
Tangible Book Value	KRW 7.9T
WACC	5.6

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.7
Net Working Capital	KRW 301B
Quick ratio	0.59
Working Capital	KRW 1.9T
Working Capital Turnover	KRW 2.7

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	11.47%
200-day SMA	1,641
3Y total return	45.59%
50-day SMA	1,576
50-day SMA vs 200-day SMA	50under200
5Y total return	45.86%
All Time High	1,987,000
All Time High Change	-25.92%
All Time High Date	2026-01-15
All Time Low	192,960.8
All Time Low Change	662.85%
All Time Low Date	2016-11-10
ATR	38,635.5
Beta	0.26
Beta1y	0.31
Beta2y	0.31
Ch YTD	-13.16
High	1,485,000
High52	1,987,000
High52 Date	2026-01-15
High52ch	-25.92%
Low	1,455,000
Low52	1,455,000
Low52 Date	2026-05-08
Low52ch	1.17%
Ma50ch	93,301.02%
Price vs 200-day SMA	89,601.4%
RSI	37.4
RSI Monthly	48.03
RSI Weekly	38.53
Sharpe ratio	0.44x
Sortino ratio	0.85
Tr YTD	-13.16
Tr1m	-7.19%
Tr1w	-0.88%
Tr3m	-11.75%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	KRW 2.2T
Operating Income Growth	40.09
Operating Income Growth Q	19.38
Operating Income Growth3 Y	30.52
Operating Income Growth5 Y	48.8
Operating margin	46.14

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	11,830,325%
Shares Insiders	0.01%
Shares Institutions	13.43%
Shares Out	46,290,951

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	58,285.6x
Ch1m	-7.19
Ch1w	-0.88
Ch1y	-8.03
Ch3m	-11.75
Ch3y	20.12
Ch5y	19.08
Ch6m	-21.59
Change	0.27%
Change From Open	0.14
Close	1,468,000
Days Gap	0.14
Depreciation Amortization	628,645,561,400
Dollar Volume	92,284,096,000
Earnings Date	2026-04-22
EBIT	KRW 2.2T
F Score	5
Fiscal Year End	December
Founded	2,011
Income Tax	KRW 569B
Is Primary Listing	1
Last Earnings Date	2026-04-22
Last Report Date	2026-03-31
Last Split Date	2025-10-30
Last Split Type	Reverse
Ma150	1,659
Ma150ch	88,628.15%
Ma20	1,535
Ma20ch	95,795.77%
Next Earnings Date	2026-07-22
Open	1,470,000
Position In Range	56.67
Price Date	2026-05-08
Ptbv Ratio	8.6
Relative Volume	1.08x
Revenue	4,814,000,000,000x
Tax By Revenue	11.82x
Tax Rate	24.52%
Tr6m	-4.96%
Volume	62,693
Z Score	13.26

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does KRX/207940 pay a dividend?

Capital-return profile for this ticker.

Performance

KRX/207940 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns KRX/207940?

Insider, institutional, and short-interest positioning.

Institutional ownership

+13.4%

Share of float held by funds and institutions

Insider ownership

+0.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

KRX/207940 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

37.4

Neutral momentum band

Price vs 200-day MA

+89601.4%

50/200-day relationship not available

Beta (5Y)

0.26

Less volatile than the market

Sharpe ratio

0.44

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About KRX/207940

Hub-level FAQ points readers to the deeper analysis pages.

What is the current krx/207940 stock rating?

krx/207940 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full krx/207940 analysis?

The full report lives at /stocks/krx/207940/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for krx/207940?

The latest report frames krx/207940 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the krx/207940 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.